Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune liver disease 2007.

Paolo Muratori1, Alessandro Granito, Georgios Pappas

  • 1Department of Internal Medicine, Cardioangiology, Hepatology, Alma Mater Studiorum-University of Bologna, Policlinico Sant'Orsola-Malpighi, via Massarenti 9, 40138 Bologna, Italy.

Molecular Aspects of Medicine
|December 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Foxp3<sup>+</sup> Tregs in HCC immunity and immunotherapy.

Trends in molecular medicine·2026
Same author

Actin-specific smooth muscle antibodies bridge adult and juvenile autoimmune hepatitis diagnosis.

JHEP reports : innovation in hepatology·2026
Same author

An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final Analysis.

Liver cancer·2026
Same author

Primary biliary cholangitis: current insights and novel therapies.

Expert review of clinical immunology·2026
Same author

Cutting edge reviews: Battling one Neglected Tropical Disease after another.

PLoS neglected tropical diseases·2026
Same author

Letter: Double PBC-Related Autoantibody Positivity-How Essential Is It for Diagnosis?

Alimentary pharmacology & therapeutics·2026
Same journal

Toward molecular and pathology-confirmed completeness in advanced ovarian cancer cytoreduction: Intraoperative molecular imaging and integrated theranostic strategies.

Molecular aspects of medicine·2026
Same journal

Gut microbiota dysbiosis in chronic liver disease: Mechanisms driving hepatocellular carcinoma progression and therapeutic implications of Chinese medicine.

Molecular aspects of medicine·2026
Same journal

Mechanisms of resistance to androgen deprivation therapy in prostate cancer.

Molecular aspects of medicine·2026
Same journal

Extracellular vesicles and their cargo molecules for peripheral nerve injuries and neuropathies: The composition, properties, and impact.

Molecular aspects of medicine·2026
Same journal

Unravelling the mystery of hypoxia-induced miRNAs in breast cancer: A molecular cross-talk driving tumour progression and therapy resistance.

Molecular aspects of medicine·2026
Same journal

Decoding the dialogue: The vagus nerve at the interface of brain, body, and Tumor.

Molecular aspects of medicine·2026
See all related articles

Autoimmune liver diseases (ALD) present diversely, diagnosed via autoantibodies like ANA, SMA, LKM1, LC1, and AMA. Treatment involves immunosuppressants or ursodeoxycholic acid, with liver transplantation for end-stage disease.

Area of Science:

  • Hepatology
  • Immunology
  • Internal Medicine

Background:

  • Autoimmune liver diseases (ALD) encompass autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and overlap syndromes.
  • These conditions exhibit significant heterogeneity in presentation, ranging from asymptomatic to chronic symptoms like fatigue and myalgia.

Purpose of the Study:

  • To outline the diagnostic role of autoantibodies in autoimmune liver diseases.
  • To describe current treatment strategies for ALD.

Main Methods:

  • Characterization of non-organ-specific autoantibodies (ANA, SMA, LKM1, LC1, AMA, atypical p-ANCA).
  • Review of therapeutic approaches including immunosuppressive therapy and ursodeoxycholic acid.

Main Results:

Related Experiment Videos

  • Specific autoantibodies are associated with different ALD subtypes: ANA/SMA for AIH type 1, LKM1/LC1 for AIH type 2, AMA for PBC.
  • Atypical p-ANCA is found in a notable portion of AIH type 1 cases.
  • No specific marker is identified for PSC.

Conclusions:

  • Autoantibody detection is crucial for diagnosing autoimmune liver diseases.
  • Treatment strategies vary based on disease type, with liver transplantation as a last resort for advanced disease.